gi exam 1 drugs

0.0(0)
studied byStudied by 18 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/83

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

84 Terms

1
New cards

lansoprazole brand

prevacid

2
New cards

lansoprazole class

ppi

3
New cards

lansoprazole moa

proton pump inhibition

4
New cards

lansoprazole AEs

increased incidence of osteoporosis-related bone fractures of the hip, spine, or wrist; may diminish the therapeutic effect of clopidogrel; increased risk of c diff

5
New cards

lansoprazole dose

15-30 mg po qd

6
New cards

lansoprazole contraindications

hepatic (consider dose adjustment with severe impairment)

7
New cards

lansoprazole BBW

none

8
New cards

dexlansoprazole brand

dexilant

9
New cards

dexlansoprazole class

ppi

10
New cards

dexlansoprazole moa

proton pump inhibition

11
New cards

dexlansoprazole AEs

increased incidence of osteoporosis-related bone fractures of the hip, spine, or wrist; may diminish the therapeutic effect of clopidogrel; increased risk of c diff

12
New cards

dexlansoprazole dose

healing: 60 mg po qd x up to 8 weeks maintenance: 30 mg po qd

13
New cards

dexlansoprazole contraindications

hepatic (consider dose adjustment with severe impairment)

14
New cards

dexlansoprazole BBW

none

15
New cards

pantoprazole brand

protonix

16
New cards

pantoprazole class

ppi

17
New cards

pantoprazole moa

inhibits gastric cell hydrogen-potassium ATPase

18
New cards

pantoprazole AEs

diarrhea, headache, abdominal pain, nausea, flatulence, dizziness, vertigo, myalgia

19
New cards

pantoprazole dose

20 mg PO/IV qd

20
New cards

pantoprazole contraindications

none

21
New cards

pantoprazole bbw

none

22
New cards

omeprazole brand

prilosec

23
New cards

omeprazole class

ppi

24
New cards

omeprazole moa

inhibits gastric cell hydrogen-potassium ATPase

25
New cards

omeprazole dose

20 mg PO qd

26
New cards

omeprazole AEs

diarrhea, headache, abdominal pain, nausea, flatulence, dizziness, rash, upper respiratory infection

27
New cards

omeprazole contraindications

none

28
New cards

omeprazole bbw

none

29
New cards

esomeprazole brand

nexium

30
New cards

esomeprazole class

ppi

31
New cards

esomeprazole moa

inhibits gastric cell hydrogen-potassium ATPase

32
New cards

esomeprazole AEs

diarrhea, headache, abdominal pain, nausea, vomiting, flatulence, dizziness

33
New cards

esomeprazole dose

20-40 mg PO QD

34
New cards

esomeprazole contraindications

none

35
New cards

esomeprazole bbw

none

36
New cards

famotidine brand

pepcid

37
New cards

famotidine class

histamine blocker (h2)

38
New cards

famotidine moa

antagonizes H2 histamine receptors

39
New cards

famotidine dose

20-40 mg po qd

40
New cards

famotidine AEs

dizziness, headache, taste changes, constipation, diarrhea

41
New cards

famotidine bbw

none

42
New cards

famotidine contraindications

none

43
New cards

ibuprofen brand

advil, motrin

44
New cards

ibuprofen class

nsaid

45
New cards

ibuprofen moa

inhibits cyclooxygenase, reducing prostaglandin and thromboxane synthesis

46
New cards

ibuprofen dose

peds: 5-10 mg/kg q 6-8hrs adult: 300-800 mg tid-qid

47
New cards

ibuprofen AEs

dyspepsia, nausea, abdominal pain, constipation, headache, drowsiness, photosensitivity

48
New cards

ibuprofen contraindications

ASA/nsaid induced asthma, 2nd/3rd trimester of pregnancy, CABG side effects

49
New cards

ibuprofen bbw

may increase risk of CV thrombotic events, may increase risk of fatal GI events

50
New cards

meloxicam brand

mobic

51
New cards

meloxicam class

nsaid

52
New cards

meloxicam moa

inhibits cyclooxygenase, reducing prostaglandin and thromboxane synthesis

53
New cards

meloxicam dose

7.5-15 mg po qd

54
New cards

meloxicam AEs

dyspepsia, nausea, abdominal pain, dizziness, headache, rash, constipation, edema

55
New cards

meloxicam contraindications

aspirin/nsaid allergy, pregnancy, 2nd/3rd trimester

56
New cards

meloxicam bbw

may increase risk of cv thrombotic events, may increase risk of fatal GI events

57
New cards

naproxen brand

naprosyn naprelan

58
New cards

naproxen class

nsaid

59
New cards

naproxen moa

inhibits cyclooxygenase, reducing prostaglandin and thromboxane synthesis

60
New cards

naproxen dose

IR/DR: 250-500 po q12hr ER: 750-1000 mg po qd

61
New cards

naproxen AEs

dyspepsia, nausea, abdominal pain, constipation, headache, drowsiness, photosensitivity

62
New cards

naproxen contraindications

ASA/NSAID induced asthma, 2nd/3rd trimester of pregnancy, cabg side effects

63
New cards

naproxen bbw

may increase risk of CV thrombotic events, may increase risk of fatal GI events

64
New cards

celecoxib brand

celebrex

65
New cards

celecoxib class

cox-2 inhibitor

66
New cards

celecoxib moa

selectively inhibits cox-2 and reduces prostaglandin synthesis

67
New cards

celecoxib dose

100-200 mg po qd-bid

68
New cards

celecoxib AEs

headache, diarrhea, nausea, vomiting, peripheral edema, photosensitivity

69
New cards

celecoxib contraindications

hypersensitivity to sulfonamides, pregnancy after 1st trimester

70
New cards

celecoxib bbw

may increase risk of cv thrombotic events, may increase risk of fatal gi events

71
New cards

diclofenac brand

voltaren

72
New cards

diclofenac class

nsaid

73
New cards

diclofenac moa

inhibits cyclooxygenase, reducing prostaglandin and thromboxane synthesis

74
New cards

diclofenac dose

DR: 50 mg po bid-tid ER: 100 mg po qd

75
New cards

diclofenac AEs

dyspepsia, vomiting, headache, dizziness, rash, drowsiness, fluid retention

76
New cards

diclofenac contraindications

aspirin or nsaid allergy, pregnancy 2nd or 3rd trimester

77
New cards

diclofenac bbw

may increase risk of cv thrombotic events, may increase risk of fatal GI events

78
New cards

ketorolac brand

toradol, sprix

79
New cards

ketorolac class

nsaid

80
New cards

ketorolac moa

inhibits cyclooxygenase, reducing prostaglandin and thromboxane synthesis

81
New cards

ketorolac dose

10 mg po q4-6hrs prn

82
New cards

ketorolac AEs

GI bleeding, perforation, or ulcer, dyspepsia, nausea, abdominal pain, constipation, headache, drowsiness, photosensitivity

83
New cards

ketorolac contraindications

major surgery pre-op, ASA/NSAID induced asthma, epidural or intrathecal use, CABG Sx

84
New cards

ketorolac bbw

oral - up to 5 days treatment and only after parenteral use all - may increase risk of CV thrombotic events; may increase risk of fatal GI events